PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)

NCT03809988 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

198

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Advanced Breast Cancer
Hormone Receptor Positive Tumor
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Interventions

DRUG: Palbociclib
DRUG: Endocrine therapy

Sponsor

MedSIR

Collaborators

[object Object]